Xenon Pharmaceuticals Inc. XENE
38.78 USD 0.00 (+0.00%)
Regular-session close
38.07 -0.71 -1.83%
Pre-market · Nov 18, 9:22 AM ET
38.23 Day range 39.47
33.38 52-week range 72.66
- YTD
- -13.48%
- 1 year
- -4.51%
News
benzinga.com JP Morgan Maintains Overweight on Xenon Pharmaceuticals, Lowers Price Target to $80 JP Morgan analyst Tessa Romero maintains Xenon Pharmaceuticals (NASDAQ:XENE) with a Overweight and lowers the price target from $82 to $80.
zacks.com Xenon Stock Rises 12% in the Past Month on Pipeline Progress XENE's shares jump 12% as azetukalner advances, pain candidates deliver encouraging results and a strong cash position supports pipeline growth.
benzinga.com Xenon Pharmaceuticals Q3 2026 Earnings Call Transcript Xenon Pharmaceuticals (NASDAQ:XENE) reported third-quarter financial results on Monday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is…benzinga.com Xenon Pharmaceuticals Q3 EPS $(1.11) Beats $(1.13) Estimate Xenon Pharmaceuticals (NASDAQ:XENE) reported quarterly losses of $(1.11) per share which beat the analyst consensus estimate of $(1.13) by 1.77 percent. This is a 3.48 percent increase over losses of…
benzinga.com Xenon Pharmaceuticals Announces Its XEN1701 Surpasses Target Profile; Data Presented During International Association For The Study Of Pain 2026 World Congress On Pain Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for…
